Loading cancer entity…
Loading cancer entity…
Clinical trials
341 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05440357 | Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study | unknown | — | 100 | Xinhua Zhang, MDOTHER | 1 | Feb 26, 2025 | clinicaltrials |
| NCT06431451 | The Correlation Between Ripretinib Exposure and the Efficacy and Safety in Patients with Advanced GISTs | unknown | — | 60 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Feb 26, 2025 |
| clinicaltrials |
| NCT01541709 | Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI | unknown | Phase 2 | 23 | Asan Medical CenterOTHER | 1 | Jan 2, 2024 | clinicaltrials |
| NCT04927260 | French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients(AVIATOR2020) | unknown | — | 25 | Centre Leon BerardOTHER | 1 | Dec 26, 2023 | clinicaltrials |
| NCT04198337 | Endoscopic Full Thickness Resection for Gastric GIST(EFTR) | unknown | N/A | 30 | Chinese University of Hong KongOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT05453292 | Endoscopic Ultrasound Radiofrequency Ablation for GISTs | unknown | N/A | 30 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05474794 | Detective Flow Imaging Endoscopic Ultrasonography in Subepithelial Lesions | unknown | N/A | 30 | Instituto Ecuatoriano de Enfermedades DigestivasOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT02365441 | A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)(ALT GIST) | unknown | Phase 2 | 78 | Australasian Gastro-Intestinal Trials GroupNETWORK | 10 | Jul 7, 2023 | clinicaltrials |
| NCT05895942 | Exploring the Molecular Mechanism Based on KIT Mutation(EMMBKM) | unknown | — | 190 | Xijing HospitalOTHER | 1 | Jun 9, 2023 | clinicaltrials |
| NCT04138381 | Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)(SeliGIST) | unknown | Phase 1 / Phase 2 | 30 | Grupo Espanol de Investigacion en SarcomasOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT03475953 | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors(REGOMUNE) | unknown | Phase 1 / Phase 2 | 747 | Institut BergoniéOTHER | 1 | Mar 3, 2023 | clinicaltrials |
| NCT05697107 | Ripretinib in Chinese Patients With Advanced GIST: a Real World Study | unknown | — | 308 | Peking UniversityOTHER | 1 | Jan 25, 2023 | clinicaltrials |
| NCT05665868 | Study on Integrated Nursing Strategy for Patients With Gastrointestinal Stromal Tumors After Targeted Therapy | unknown | N/A | 62 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Dec 27, 2022 | clinicaltrials |
| NCT05641233 | Preoperative Radiotherapy in Patients at High Risk of Postoperative Pancreatic Fistula After Pancreatoduodenectomy(FIBROPANC-1) | unknown | Phase 1 / Phase 2 | 33 | Erasmus Medical CenterOTHER | 1 | Dec 7, 2022 | clinicaltrials |
| NCT05354388 | Ripretinib Combined With Surgery in Advanced GIST That Have Failed Imatinib Therapy: A Multicenter,Observational Study | unknown | — | 30 | Sichuan Provincial People's HospitalOTHER | 1 | Apr 29, 2022 | clinicaltrials |
| NCT04825470 | Liver Transplantation for Unresectable GIST Liver Metastases(TRANSGIST) | unknown | N/A | 50 | Hospital Universitario Virgen de la ArrixacaOTHER | 1 | Mar 11, 2022 | clinicaltrials |
| NCT05197933 | Safety of Laparoscopic Resection for Gastrointestinal Stromal Tumor on Unfavorable Anatomic Site of Stomach | unknown | N/A | 182 | RenJi HospitalOTHER | 1 | Jan 20, 2022 | clinicaltrials |
| NCT04751591 | Study On Safety Of Endoscopic Resection For 2-5cm Gastric Gastrointestinal Stromal Tumor | unknown | N/A | 260 | Shanghai Zhongshan HospitalOTHER | 0 | Nov 30, 2021 | clinicaltrials |
| NCT05132738 | Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib Therapy | unknown | N/A | 20 | RenJi HospitalOTHER | 1 | Nov 24, 2021 | clinicaltrials |
| NCT05001204 | 68Ga-NOTA-RM26 PET/CT for the Detection of Gastrointestinal Stromal Tumor | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Aug 11, 2021 | clinicaltrials |
| NCT04761172 | NIR Fluorescence Imaging With ICG for the Intraoperative Identification of Gastrointestinal Stromal Cell Tumours | unknown | Phase 2 / Phase 3 | 10 | Leiden University Medical CenterOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT04143048 | A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and Malignant Nodules | unknown | — | 300 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | May 11, 2020 | clinicaltrials |
| NCT01178307 | Symptom Inventory for Gastrointestinal Stromal Tumors | unknown | — | 187 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 13, 2020 | clinicaltrials |
| NCT03139487 | A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism(PRIORITY) | unknown | Phase 2 | 176 | Asan Medical CenterOTHER | 1 | Jan 6, 2020 | clinicaltrials |
| NCT03862768 | Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment | unknown | N/A | 92 | Shanghai Zhongshan HospitalOTHER | 0 | Mar 5, 2019 | clinicaltrials |
| NCT03092128 | A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment | unknown | — | 200 | Xueding WangOTHER | 1 | Sep 13, 2018 | clinicaltrials |
| NCT03601234 | Laparoscopic Endoscopic Cooperative Surgery in the Treatment of Gastric Stromal Tumors(LECSINGST) | unknown | N/A | 80 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT02336724 | A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor | unknown | Phase 2 | 88 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 17, 2018 | clinicaltrials |
| NCT02763748 | the Laparoscopic and Endoscopic Cooperative Surgery of Gastrointestinal Stromal Tumor | unknown | N/A | 120 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Feb 7, 2018 | clinicaltrials |
| NCT03171389 | POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST(POETIG) | unknown | Phase 2 | 81 | Sebastian BauerOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT03082079 | Long Outcome of Endoscopic Submucosal Dissection for Small Gastrointestinal Stromal Tumors (<2cm) | unknown | N/A | 90 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | May 16, 2017 | clinicaltrials |
| NCT02443948 | Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST) | unknown | — | 60 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT02931981 | Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor | unknown | — | 50 | RenJi HospitalOTHER | 1 | Oct 13, 2016 | clinicaltrials |
| NCT02866045 | EUS-FNB vs. Single-incision Needle-knife (SINK) Biopsy for Gastrointestinal SELs | unknown | Phase 3 | 104 | Unity Health TorontoOTHER | 1 | Aug 15, 2016 | clinicaltrials |
| NCT02776878 | A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST | unknown | N/A | 57 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 18, 2016 | clinicaltrials |
| NCT02576080 | Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index(GIGIST) | unknown | Phase 3 | 80 | Assistance Publique Hopitaux De MarseilleOTHER | 0 | Oct 15, 2015 | clinicaltrials |
| NCT02426762 | Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery | unknown | Phase 2 | 100 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT01389583 | A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients | unknown | Phase 2 | 25 | National Health Research Institutes, TaiwanOTHER | 1 | Feb 25, 2015 | clinicaltrials |
| NCT02353052 | Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of GIST | unknown | — | 900 | Shanghai Zhongshan HospitalOTHER | 1 | Feb 2, 2015 | clinicaltrials |
| NCT02246322 | A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions.(EUS-FNA) | unknown | N/A | 144 | Istituto Clinico HumanitasOTHER | 1 | Sep 22, 2014 | clinicaltrials |
| NCT00685828 | Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor | unknown | Phase 3 | 946 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Jul 4, 2014 | clinicaltrials |
| NCT01381822 | Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors(TH-CR-410) | unknown | Phase 1 | 58 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 21, 2014 | clinicaltrials |
| NCT01227746 | A Retrospective Study of C-kit Mutation Status in Asian Patients With Advanced Gastro-intestinal Stromal Tumors (GIST) Treated With Imatinib. | unknown | — | — | National University Hospital, SingaporeOTHER | 1 | Jan 22, 2014 | clinicaltrials |
| NCT01768104 | ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors | unknown | N/A | 200 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jan 15, 2013 | clinicaltrials |
| NCT00777504 | Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors | unknown | Phase 4 | 30 | Radboud University Medical CenterOTHER | 1 | Sep 16, 2011 | clinicaltrials |
| NCT00687778 | 11C-Acetate PET/CT Non-FDG-Avid Tumors | unknown | — | 100 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jun 2, 2008 | clinicaltrials |
| NCT00290485 | Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST) | unknown | Phase 2 | 50 | Maisonneuve-Rosemont HospitalOTHER | 1 | Apr 7, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Feb 26, 2025source: clinicaltrials